Lv41
670 积分 2023-01-28 加入
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
1小时前
待确认
Fifty years of monoclonals: the past, present and future of antibody therapeutics
1个月前
已完结
Humanized mouse models for immuno-oncology research
1个月前
已完结
Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
5个月前
已完结
Drug-to-Antibody Ratio (DAR) and Drug Load Distribution by Hydrophobic Interaction Chromatography and Reversed Phase High-Performance Liquid Chromatography
11个月前
已完结
Discovery of ILC2 extracellular traps and ILC2 ETosis: A novel feature of group 2 innate lymphoid cells
1年前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
1年前
已完结
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs
1年前
已完结
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
1年前
已完结
皖公网安备34019202002308
